document type sequence filename cala description text doctype html public html transitional http html loose html converter body style margin bottom margin text indent font family time roman font size nbsp style text align right margin bottom margin font weight bold font size font family arial font style normal text transform none font variant normal text indent exhibit style text align justify margin bottom margin font weight bold font size font family arial font variant small font style normal text transform none text indent certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style text align center margin bottom margin text indent font weight bold font size font family arial font variant small font style normal text transform none collaboration license agreement style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal this font style font weight bold collaboration license agreement font font style font weight bold agreement font made entered into effective december font style font weight bold font font style font weight bold font font style font weight bold effective date font between nbsp nbsp style margin margin bottom text indent font weight bold font family arial font size font style normal text transform none font variant normal calithera bioscience font style font weight normal font font style font weight normal delaware corporation located oyster point boulevard suite south francisco font calithera font style font weight normal font style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal style margin margin bottom text indent font weight bold font family arial font size font style normal text transform none font variant normal font style font weight normal font font style font variant small font font style font weight normal delaware corporation through font symbioscience font style font weight normal division having place business seneca meadow parkway germantown maryland font symbioscience font style font weight normal nbsp nbsp font style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal symbioscience calithera each referred herein individually font style font weight bold party font collectively font style font weight bold party font style text align center margin margin bottom text indent font weight bold font family arial font variant small font size font style normal text transform none recital style margin margin bottom text indent font weight bold font family arial font variant small font size font style normal text transform none font style font weight normal font variant normal symbioscience control certain patent other intellectual property pertaining arginase inhibitor their including pharmaceutical application human healthcare font style margin margin bottom text indent font weight bold font family arial font size font style normal text transform none font variant normal font style font weight normal symbioscience calithera desire enter into collaboration whereby calithera will develop manufacture commercialize arginase inhibitor font style margin margin bottom text indent font weight bold font family arial font size font style normal text transform none font variant normal font style font weight normal calithera desire obtain exclusive license under symbioscience intellectual property right purpose developing manufacturing commercializing pharmaceutical product containing arginase inhibitor symbioscience desire grant calithera such license term condition forth this agreement font style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal consideration foregoing premise mutual promise covenant forth this agreement other good valuable consideration receipt sufficiency which hereby acknowledged symbioscience calithera hereby agree follows style text align center margin margin bottom text indent font weight bold font family arial font variant small font size font style normal text transform none agreement align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color definition font table style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal when used this agreement following capitalized term will have meaning defined below nbsp nbsp unless context indicates otherwise singular will include plural plural will include singular style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color affiliate font font style font weight normal color mean with respect party corporation firm partnership other entity that directly indirectly control controlled under common control with such party only long such control exists nbsp nbsp used this definition control mean with correlative meaning term controlled under common control with that applicable entity actual ability direct manage business affair party whether through ownership directly indirectly more than fifty percent share stock entitled vote election director party case corporation more than fifty percent equity interest case other type legal entity status general partner partnership contract other arrangement whereby such entity control right control business affair party nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color arginase inhibitor font font style font weight normal color mean small molecule that inhibits activity enzyme arginase arginase both font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color commercialization font font style font weight normal color mean activity relating manufacture marketing obtaining pricing reimbursement approval promotion advertising importing selling distribution customer support licensed product country nbsp nbsp term font font style color commercialize font font style font weight normal color correlative meaning font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color commercially reasonable effort font font style font weight normal color mean with respect task obligation conducted party under this agreement with respect developing commercializing licensed product carrying such activity using good faith effort equivalent those effort resource that similarly situated pharmaceutical development company would reasonably devote developing commercializing therapeutic product that similar market potential similar stage product life similar therapeutic area taking into account applicable market business legal factor such competitiveness market including alternative product proprietary intellectual property position product likelihood regulatory approval including consideration safety efficacy given regulatory authority structure involved potential profitability market size product other similar factor font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color controlled font font style font weight normal color mean with respect know patent other intellectual property right that applicable party owns license under such know patent other intellectual property right ability assign other party grant other party license sublicense other right under such know patent right provided herein without violating term agreement other arrangement with third party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal name _toc font style font weight normal color font font style color development font font style font weight normal color mean clinical clinical drug discovery research development activity reasonably related leading development submission information regulatory authority including compound screening medicinal chemistry chemical synthesis toxicology pharmacology other discovery clinical effort test method development stability testing manufacturing process development formulation development delivery system development quality assurance quality control development manufacturing statistical analysis clinical study nbsp nbsp when used verb font font style text decoration underline font weight normal color develop font font style font weight normal color mean engage development font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color font font style font weight normal color mean united state food drug administration successor agency thereto font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color field font font style font weight normal color mean human healthcare including therapeutic prophylactic preventative diagnostic nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color first commercial sale font font style font weight normal color mean with respect given licensed product particular country first sale third party such licensed product country after obtaining required marketing approval such country nbsp nbsp first commercial sale shall include supply licensed product clinical trial compassionate font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color font font style font weight normal color mean long term safety study appropriate animal specie usually rodent mammal under good laboratory practice guideline described part which design result suitable support filing nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color font font style font weight normal color mean investigational drug application filed with sufficient satisfy requirement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color indication font font style font weight normal color font font style color font font style font weight normal color mean font font style color font font style font weight normal color first approval each subsequently approved font font style font style italic font weight normal color indication usage font font style font weight normal color described code federal regulation labeling requirement part labeling that substantiated with least pivotal clinical study previously submitted within submission font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal name _toc font style font weight normal color font font style color know font font style font weight normal color mean public documented otherwise recorded memorialized knowledge experience know technology technical information result trade secret data other information including formula formulation process technique unpatented invention discovery idea development test procedure result together with document file embodying foregoing including relevant proprietary material font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color licensed compound font font style font weight normal color mean arginase inhibitor that nbsp nbsp such country tier compound such country that that included above tier compound font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color licensed know font font style font weight normal color mean know that necessary reasonably needed research development manufacture commercialization arginase inhibitor field controlled symbioscience effective date during term agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color licensed patent font font style font weight normal color mean patent symbioscience effective date listed font font style text decoration underline font weight normal color exhibit font font style font weight normal color including other patent issuing arising from such patent foreign equivalent foregoing patent controlled symbioscience during term that font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color licensed product font font style font weight normal color mean pharmaceutical preparation final form containing licensed compound active ingredient either alone combination with more other active ingredient nbsp nbsp tier product mean licensed product sold country where licensed compound such licensed product tier compound font font style font style italic font weight normal color font font style font weight normal color such compound such country tier product mean licensed product sold country where licensed compound such licensed product tier compound font font style font style italic font weight normal color font font style font weight normal color such compound meet criterion subsection such country nbsp nbsp avoidance doubt licensed product shall mean food dietary supplement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color licensed technology font font style font weight normal color mean licensed patent licensed know font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color major european market font font style font weight normal color mean following country france germany italy spain united kingdom nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color major market country font font style font weight normal color mean united state america country major european market nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color marketing approval font font style font weight normal color mean with respect licensed product approval registration license permit regulatory authority country including pricing reimbursement approval that necessary obtained order market sell commercially such licensed product that country font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color font font style font weight normal color mean filing marketing approval licensed product including without limitation drug application filed with united state food drug administration more fully defined font font style font style italic font weight normal color font font style font weight normal color marketing authorization application filed with european medicine agency foreign equivalent font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color sale font font style font weight normal color shall mean amount invoiced calithera affiliate sublicensees commercial sale licensed product third party purchaser following deduction extent applicable such sale licensed product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color normal customary charge packaging transportation freight insurance actually incurred charged purchaser separately shipping delivery licensed product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color sale value added excise custom duty other governmental charge imposed upon sale licensed product paid selling party other than franchise income kind font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color length paid third party consignee agent connection with sale licensed product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color reasonable customary rebate quantity discount charge back allowance premium granted allowed connection with sale licensed product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color credit allowance given made rejection return uncollectible amount previously sold licensed product retroactive price reduction font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color credit allowance customer account governmental managed care requirement licensed product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color debt actually written connection with such licensed product licensed product sale applicable royalty period font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal viii font style font weight normal color cost customer program such cost effectiveness patient assistance study program designed patient compliance with medication schedule connection with sale licensed product nbsp nbsp font style margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal sale shall determined accordance with gaap ifrs applicable nbsp nbsp purpose calculating sale party recognize that calithera affiliate sublicensee customer include person chain commerce enter into agreement with selling party price even though title licensed product directly from selling party such customer even though payment purchase such licensed product made directly such customer nbsp nbsp such case charge back paid calithera through such third party such wholesaler deducted calithera affiliate sublicensee applicable from gross revenue order calculate sale nbsp nbsp deduction listed above which involve payment calithera affiliate sublicensee shall taken deduction against aggregate sale period which payment deduction made nbsp nbsp sale licensed product solely research clinical testing purpose shall excluded from computation sale style margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal event that licensed product sold package with other product discount applied licensed product determine sale shall greater than average discount entire package nbsp nbsp style margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal event licensed product sold form combination product containing more active ingredient addition licensed compound sale such combination product purpose calculating royalty sale milestone payment based such sale country country basis will adjusted multiplying actual sale such combination product determined above fraction where invoice price licensed compound such licensed product sold separately licensed product without other active ingredient invoice price other active ingredient ingredient combination product sold separately country country basis other active ingredient ingredient combination sold separately that country sale shall calculated multiplying actual sale such combination product fraction where amount determined above invoice price combination product sold nbsp nbsp country country basis other active ingredient ingredient combination sold separately that country licensed compound sold separately licensed product sale shall calculated multiplying actual sale such combination product fraction where calculated provided above nbsp nbsp country country basis neither licensed product other active component component combination product sold separately said country thus above determined with respect such sale such country fraction applied determine adjusted sale such combination product shall fraction reflecting relative fair market value contribution licensed compound such combination product total market value such combination product determined party reasonably good faith prior first commercial sale relevant combination product nbsp nbsp event that party unable agree relative fair market value party shall agree upon internationally recognized independent pharmaceutical executive with significant experience pharmaceutical pricing valuation shall engaged party make such determination whose determination shall final binding party with party sharing cost such engagement nbsp nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color patent font font style font weight normal color mean patent patent application country supranational jurisdiction substitution division continuation continuation part reissue renewal registration confirmation examination extension supplementary protection certificate like provisional application such patent patent application foreign equivalent foregoing font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color phase clinical trial font font style font weight normal color shall mean human clinical trial licensed product that would satisfy requirement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color phase clinical trial font font style font weight normal color shall mean human clinical trial licensed product that would satisfy requirement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color phase clinical trial font font style font weight normal color mean clinical study human efficacy safety licensed product that prospectively designed demonstrate with statistical significance that such product effective safe particular indication manner sufficient file marketing approval such product would satisfy requirement font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color regulatory authority font font style font weight normal color mean federal state local regulatory agency department bureau other government entity including which responsibility granting license approval granting pricing reimbursement approval necessary marketing sale licensed product country font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color sublicense agreement font font style font weight normal color mean agreement entered into accordance with section under which calithera grant third party sublicense option other right relating licensed technology allowing such third party develop commercialize more licensed product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color sublicensee font font style font weight normal color mean third party that entered into sublicense agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color term font font style font weight normal color meaning assigned section font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color territory font font style font weight normal color mean country world font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color third party font font style font weight normal color mean party other than symbioscience calithera their respective affiliate font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color tier product font font style font weight normal color mean licensed product that contains tier compound active pharmaceutical ingredient font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color tier product font font style font weight normal color mean licensed product that contain tier compound active pharmaceutical ingredient contains clarity tier compound active pharmaceutical ingredient nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color font font style color valid claim font font style font weight normal color mean pending claim pending patent application within licensed patent that been abandoned disclaimed finally rejected with further possibility appeal claim issued unexpired patent within licensed patent that been disclaimed abandoned held invalid unenforceable judgment decree entered judicial proceeding that further appealable nbsp nbsp font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color license font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color license grant font font style font weight normal color nbsp nbsp subject term condition this agreement font font style color font font style font weight normal color symbioscience hereby grant calithera exclusive worldwide royalty bearing license font font style font weight normal with right grant sublicenses through multiple tier accordance with section font font style font weight normal color under licensed technology research have researched develop have developed make have made have used sell have sold offer sale have offered sale promote have promoted export have exported import have imported licensed product field territory font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color reservation right restrictive covenant font font style font weight normal color nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color implied license granted under this agreement symbioscience reserve right technology except right licensed calithera under section nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color order preserve exclusivity symbioscience covenant that affiliate will during symbioscience will time during term calithera will from after time that calithera will undertake directly through third party which that nbsp nbsp font font style font style italic font weight normal strike strike font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color while exclusive license granted calithera limited field symbioscience covenant agrees that affiliate shall develop commercialize license otherwise permit other party product outside field that contains licensed compound during thereafter licensed compound reserved calithera licensed product field calithera reserved compound nbsp nbsp time after symbioscience request calithera shall provide writing within business list reserved compound list reserved compound which clarity font font style font style italic font weight normal color provided that font font style font weight normal color that including other than reserved compound nbsp nbsp from time time thereafter calithera modify such reserved compound list substituting more other licensed compound reserved compound then such list each case subject following procedure nbsp nbsp calithera wish modify reserved compound list shall submit symbioscience list substitution list licensed compound that calithera desire reserved compound reserve compound list particular licensed compound existing reserved compound list each such licensed compound desired added reserved compound list that calithera desire remove from such list thereby delete reserved compound while remaining clarity licensed compound nbsp nbsp each such licensed compound that calithera proposes particular substitution list font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color reserved compound list reserved compound shall date thirty business after calithera submits such substitution list symbioscience automatically added reserved compound list reserved compound respective licensed compound that calithera indicates such substitution list remove exchange substitution such reserved compond from reserved compound list shall then automatically removed from reserved compound list longer reserved compound font font style font style italic font weight normal color unless font font style font weight normal color symbioscience delivers calithera date thirty business after calithera submits such substitution list symbioscience documentary evidence demonstrating calithera reasonable satisfaction that with respect such licensed compound that calithera proposed such substitution list reserved compound with respect such such licensed compound that calithera proposed reserved compound nbsp nbsp event that either circumstance subclauses exist symbioscience shall have notified calithera writing within business receipt such substitution list such circumstance have provided such documentary evidence calithera required above then relevant licensed compound covered such circumstance shall added reserved compound list shall remain licensed compound calithera shall permitted request substitute therefor submitting substitution list such compound other license compound prior substitution list that added reserved compound list foregoing pursuant above procedure font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color event that symbioscience decides pursue authorize third party pursue which pursuit must event accordance with restriction section symbioscience shall give written notice calithera specifying reasonable detail program that symbioscience intends pursue offer nbsp nbsp calithera shall have thirty after date offer provide written response symbioscience response whether wish enter into negotiation with symbioscience with respect right such program nbsp nbsp response state that calithera wish enter into negotiation with symbioscience party shall negotiate good faith licensing such right period ninety from date response nbsp nbsp response received within thirty response period calithera decline enter into negotiation party agree upon execute written agreement within ninety negotiation period after calithera response given then symbioscience shall thereafter free pursue relevant program alone with third party subject compliance with section nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal name _ref font style color right sublicense font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color calithera grant sublicenses under license forth section affiliate third party subject term condition forth section nbsp nbsp existing sublicensee good standing grant further sublicenses also subject such term condition nbsp nbsp calithera will provide symbioscience with complete copy each sublicense agreement within thirty execution such agreement shall reasonable effort obtain provide symbioscience complete copy each further sublicense soon practicable after execution thereof nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color each sublicense agreement with sublicensee each further sublicense shall consistent with subject term condition this agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color calithera will monitor compliance with reasonable effort enforce term sublicense agreement against sublicensees shall require that sublicensees also reasonable effort enforce term approved sublicense agreement with further sublicensees font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color event shall calithera affiliate sublicensee have right grant sublicense that third party under licensed patent without prior written consent symbioscience which consent shall unreasonably withheld conditioned delayed nbsp nbsp purpose hereof shall mean sublicense granted third party under licensed patent that both that relevant sublicense granted that such sublicense granted nbsp nbsp breach this section affiliate sublicensee shall deemed material breach this agreement calithera giving rise termination right provided section provided that understood agreed that calithera cure such breach either terminating sublicense agreement with sublicensee that breach this provision causing termination applicable prior date that after notice from symbioscience under section such breach font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color technology transfer font font style font weight normal color nbsp nbsp promptly after effective date symbioscience will provide calithera additional expense with reasonable assistance transitioning arginase inhibitor program calithera including providing copy licensed technology related program information including without limitation data book other report generated behalf symbioscience regarding previously conducted font font style font style italic font weight normal color vitro font font style font weight normal color font font style font style italic font weight normal color vivo font font style font weight normal color font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color study licensed compound reasonably requested calithera reasonable amount available compound sample each licensed compound such reasonable quantity agreed party providing reasonable amount consultation regarding such information status symbioscience program font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color development licensed product font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color responsibility font font style font weight normal color nbsp nbsp subject term condition this agreement including without limitation section calithera will responsible calithera expense development licensed product field territory using commercially reasonable effort nbsp nbsp calithera will conduct will cause affiliate sublicensees conduct such activity good scientific manner compliance material respect with applicable nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color record font font style font weight normal color nbsp nbsp development activity conducted behalf calithera will recorded reasonable detail good scientific manner nbsp nbsp calithera affiliate sublicensees will also retain record required applicable maintained connection with development licensed product hereunder nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color expense font font style font weight normal color font font style color nbsp nbsp font font style font weight normal color calithera will bear expense connection with development licensed product field hereunder nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color diligence nbsp nbsp font font style font weight normal color calithera will commercially reasonable effort develop obtain marketing approval least licensed product field soon reasonably practicable nbsp nbsp calithera shall provide notice symbioscience time during term decides abandon further development commercialization licensed compound licensed product nbsp nbsp such notice shall constitute notice calithera terminate will result termination agreement pursuant section nbsp nbsp event that symbioscience belief calithera material breach obligation commercially reasonable effort under this section then symbioscience notify calithera writing which notice shall provide available detail regarding basis belief specifying that such notice diligence breach notice being provided symbioscience pursuant this section nbsp nbsp diligence breach notice provided calithera calithera within further period after receipt such notice provide written report symbioscience justify calithera belief such material breach such diligence obligation nbsp nbsp such report provided calithera such time period symbioscience shall permitted terminate this agreement pursuant section nbsp nbsp calithera provides response party shall then conduct initial meeting within after delivery such written report from calithera discus good faith concern raised symbioscience shall conduct such additional meeting reasonably necessary reach agreement whether calithera material breach obligation under this section additional after such initial meeting nbsp nbsp after such period following initial meeting party reach agreement then upon request either party matter shall referred dispute resolution procedure outlined under section which procedure shall required nbsp nbsp determine whether there fact material breach calithera diligence obligation determined that there uncured material breach specify what additional effort calithera must undertake cure such breach time period during which such effort must commenced completed which time period shall commercially reasonable nbsp nbsp such procedure determines that there material breach diligence obligation hereunder calithera commence complete cure effort specified arbitration result response clause requirement above required relevant date then symbioscience terminate agreement pursuant section nbsp nbsp effort nbsp nbsp calithera affiliate third party contractor sublicensees will considered effort calithera purpose determining calithera compliance with obligation under this section nbsp nbsp font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color commercialization licensed product font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color general font font style font weight normal color nbsp nbsp calithera affiliate sublicensees will solely responsible cost using commercially reasonable effort commercialization licensed product territory during term font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color diligence font font style font weight normal color nbsp nbsp calithera affiliate sublicensee applicable will commercially reasonable effort launch each licensed product each country territory after receiving marketing approval such country nbsp nbsp thereafter calithera affiliate sublicensee applicable will commercially reasonable effort commercialize licensed product such country nbsp nbsp effort calithera affiliate third party contractor sublicensees will considered effort calithera purpose determining calithera compliance with obligation under this section font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font variant small font style normal text transform none font style font variant normal color report font font style font weight normal font variant normal color nbsp nbsp calithera shall before each anniversary effective date continuing until such time first commercial sale first licensed product occurred major market country japan provide symbioscience with summary written report status effort those affiliate sublicensees develop commercialize licensed compound licensed product addition upon request symbioscience more than once year calithera shall make representative familiar with calithera effort with respect development commercialization licensed compound licensed product available meeting half with symbioscience representative mutually agreed location teleconference discus progress report provided above prior such time first commercial sale occurred with respect licensed product each major market country japan calithera shall promptly good faith provide such information with respect such effort reasonably requested symbioscience from time time font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color manufacture licensed product font table style margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal name _toc manufacture supply font style font weight normal nbsp nbsp calithera will solely responsible using reasonable effort shall control activity relating obtaining quantity licensed product development commercialization effort territory hereunder nbsp nbsp font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color financial term font table style margin bottom margin text indent font weight bold color font size font family arial font variant small font style normal text transform none font style font variant normal color initial license font font style font weight normal font variant normal color name _toc nbsp nbsp calithera will symbioscience creditable refundable initial license dollar effective date font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color milestone payment font font style font weight normal color nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color development milestone font font style font weight normal color nbsp nbsp calithera will symbioscience following creditable refundable milestone payment within sixty following first achievement licensed product corresponding event described table below nbsp nbsp subject paragraph following table below each development milestone payment below shall paid only once upon first attainment applicable milestone event licensed product font style margin bottom margin text indent font family time roman font size nbsp table border cellspacing cellpadding align center style border collapse collapse width valign style width style text align center margin bottom margin margin left text indent font weight bold font size font family arial font variant small font style normal text transform none milestone event valign style width style text align center margin bottom margin margin left text indent font family time roman font weight bold font size nbsp colspan valign style width style text align center margin bottom margin margin left text indent font weight bold font size font family arial font variant small font style normal text transform none milestone payment valign style width style text align center margin bottom margin margin left text indent font family time roman font weight bold font size nbsp valign style width style text align center margin bottom margin margin left text indent font family time roman font weight bold font size nbsp valign style width style text align center margin bottom margin margin left text indent font weight bold font style italic font size font family arial font variant small text transform none tier product valign style width style text align center margin bottom margin margin left text indent font family time roman font weight bold font size nbsp valign style width style text align center margin bottom margin margin left text indent font weight bold font style italic font size font family arial font variant small text transform none tier product valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal valign style width style text align center margin bottom margin margin left text indent font family time roman font size nbsp valign style width style text align center margin bottom margin margin left text indent font size font family arial font weight normal font style normal text transform none font variant normal table style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal clarity each above milestone payment will paid full only once with amount certain milestone payment dependent whether tier product tier product that first meet milestone indicated table above style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal calithera also pursues development additional licensed product either category forth above product containing different active ingredient than initial tier product tier product clinical development which full payment made provided above then above milestone payment shall owed development style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal milestone commencing with milestone achieved each such additional licensed product both tier product tier product payment shall milestone payment amount forth applicable milestone above schedule such additional payment shall payable unless until relevant category provided that payment other licensed product shall with respect licensed product which style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color sale milestone font font style font weight normal color nbsp nbsp within sixty first achievement sale during calendar year licensed product aggregate following annual sale milestone event calithera will symbioscience applicable milestone payment forth schedule below specified amount dollar nbsp nbsp each sale milestone payment below shall paid only once first occurrence such milestone event subject paragraph following table below nbsp nbsp font style margin bottom margin text indent font family time roman font size nbsp table border cellspacing cellpadding align center style border collapse collapse width valign style width border solid border bottom solid border left solid style margin margin bottom margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal sale milestone style margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal aggregate sale style margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal amount calendar style margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal year valign style width border solid border bottom solid border right solid style margin bottom margin margin left text indent font family time roman font weight bold nbsp valign style width border solid border bottom solid border left solid style margin margin bottom margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal payment tier style margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal product valign style width border solid border bottom solid border right solid style margin bottom margin margin left text indent font family time roman font weight bold nbsp valign style width border solid border bottom solid border left solid border right solid style margin margin bottom margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal payment teir style margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal product valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style margin bottom margin margin left margin right text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal table style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal payment milestone achievement each above sale milestone will made only once with amount milestone payment particular sale milestone that achieved dependent whether tier product tier product being sold when sale milestone threshold achieved nbsp nbsp event that more than licensed product contributes total sale then resulting payment will proportional contribution each individual licensed product example provided font style text decoration underline exhibit font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color royalty font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color royalty rate font font style font weight normal color nbsp nbsp calithera will symbioscience royalty sale licensed product calithera affiliate sublicensees territory nbsp nbsp royalty rate shall determined licensed product licensed product country country basis based type licensed product tier product tier product being sold applicable country aggregate sale licensed product throughout territory during calendar year follows font style margin bottom margin text indent font family time roman font size nbsp table border cellspacing cellpadding align center style border collapse collapse width valign bottom style width border solid border bottom solid border left solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal royalty tier aggregate annual sale valign style width border solid border bottom solid border right solid style text align center margin bottom margin margin left text indent font family time roman font weight bold nbsp valign bottom style width border solid border bottom solid border left solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal tier style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal product valign style width border solid border bottom solid border right solid style text align center margin bottom margin margin left text indent font family time roman font weight bold nbsp valign bottom style width border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal tier style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal product valign style width border solid border bottom solid border left solid style text align justify margin margin bottom margin left margin right text indent font family arial font size font weight normal font style normal text transform none font variant normal portion aggregate sale licensed product during calendar year that equal than valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border left solid style text align justify margin margin bottom margin left margin right text indent font family arial font size font weight normal font style normal text transform none font variant normal proportion aggregate sale licensed product during calendar year that greater than equal than valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border left solid style text align justify margin margin bottom margin left margin right text indent font family arial font size font weight normal font style normal text transform none font variant normal proportion aggregate sale licensed product during calendar year that greater than equal than valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border left solid style text align justify margin margin bottom margin left margin right text indent font family arial font size font weight normal font style normal text transform none font variant normal proportion aggregate sale licensed product during calendar year that exceeds valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign style width border solid border bottom solid border right solid style text align center margin margin bottom margin left text indent font family time roman nbsp valign style width border solid border bottom solid border left solid border right solid style text align center margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color royalty reduction generic product font font style font weight normal color nbsp nbsp there more unauthorized third party selling generic version licensed product country generic product time sale licensed product country then royalty rate shall reduced such country given calendar quarter aggregate total unit sale such generic product such country such calendar quarter exceed aggregate total unit sale font font style color font font style font weight normal color such licensed product such generic product based unit volume market share such country during font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color such calendar quarter aggregate total unit sale such generic product such country such calendar quarter exceed aggregate total unit sale such licensed product such generic product such country during such calendar quarter unit sale such generic product such country such calendar quarter exceed unit sale such licensed product such generic product such country during such calendar quarter font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color royalty term font font style font weight normal color name _dv_m nbsp nbsp calithera royalty payment obligation under this section will expire with respect particular licensed product sold country licensed product licensed product country country basis upon expiration period font font style color royalty term font font style font weight normal color such licensed product such country commencing upon first commercial sale applicable licensed product such country ending upon later expiration last expire valid claim patent name _dv_m ontrolled calithera covering sale such licensed product country sale date sale year after first commercial sale such licensed product calithera affiliate sublicensees such country nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color third party obligation font font style font weight normal color calithera shall responsible payment additional third party license milestone payment royalty other license payment with respect licensed product that based agreement entered into calithera relevant affiliate sublicensee font font style font style italic font weight normal color provided however font font style font weight normal color that calithera shall entitled credit license payment including royalty paid calithera under agreement entered into calithera relevant affiliate sublicensee after effective date against royalty symbioscience hereunder relevant licensed product country font font style font style italic font weight normal color provided further font font style font weight normal color that event shall amount symbioscience from calithera with respect relevant licensed product country reduced more than amount otherwise with such amount creditable foregoing limitation reduction being carried forward future payment obligation until fully credited font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color royalty report payment font font style font weight normal color nbsp nbsp following first commercial sale licensed product which royalty pursuant section continuing long royalty hereunder within sixty after each calendar quarter calithera shall provide royalty report showing licensed product licensed product country country basis font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color sale each licensed product sold calithera affiliate sublicensees during such calendar quarter reporting period indication whether each such licensed product tier product tier product font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color royalty payable united state dollar which shall have accrued hereunder with respect such sale font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color withholding required applicable deducted with respect such royalty font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color rate exchange with supporting calculation determined accordance with section used calithera determining amount united state dollar payable hereunder font style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal calithera shall symbioscience royalty each calendar quarter time submission calithera royalty report nbsp nbsp royalty royalty period hereunder following commencement reporting obligation calithera shall report style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color currency exchange font font style font weight normal color nbsp nbsp case sale outside united state rate exchange used computing amount currency equivalent united state dollar shall rate exchange used calithera affiliate sublicensee relevant font font style color font font style font weight normal color financial reporting purpose connection with other product account which shall consistent with gaap nbsp nbsp upon request symbioscience calithera shall provide symbioscience with copy calithera affiliate sublicensee relevant then current currency exchange policy font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color record audit font font style font weight normal color font font style color record audit font font style font weight normal color calithera shall keep year from date payment amount owed hereunder accurate record sale calithera each licensed product sufficient detail allow accruing royalty milestone payment determined nbsp nbsp symbioscience shall have right period year after receiving royalty report appoint independent certified internationally recognized public accountant reasonably acceptable calithera sole purpose inspecting relevant record calithera verify relevant report upon reasonable notice from symbioscience calithera shall make such record available such inspection font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color during regular business hour such place place where such record customarily kept nbsp nbsp such inspection right shall exercised more than once calendar year more than once with respect sale licensed product given payment period nbsp nbsp result each inspection shall binding both party unless either party commences audit disagreement procedure pursuant section within from notification such result appointed accountant symbioscience shall cost such inspection except that calithera shall reasonable cost such inspection binding result result audit disagreement procedure show upward adjustment aggregate amount payable period inspected more than amount actually paid nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color audit disagreement font font style font weight normal color there dispute between party following inspection performed pursuant section either party refer issue font font style color audit disagreement font font style font weight normal color independent certified public accountant resolution event that audit disagreement submitted resolution either party party shall comply with following procedure font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color party submitting audit disagreement resolution shall provide written notice other party that invoking procedure this section font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color within thirty giving such notice party shall good faith jointly select engage recognized international independent accounting firm independent certified public accountant resolve such audit disagreement resolution firm agreement independent expert reached party within that time then accounting firm engaged resolve such audit disagreement resolution firm shall nbsp nbsp independent accounting firm that used either party that largest total revenue auditing practice united state calendar year immediately prior time dispute font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color audit disagreement submitted resolution shall described party engaged resolution firm which description written oral form within business from selection such firm description made resolution firm oral form will reduced resolution firm writing with copy provided each party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color resolution firm shall have right access review relevant record calithera needed resolve audit dispute nbsp nbsp resolution firm shall render decision matter soon practicable font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color decision resolution firm shall final binding unless such audit disagreement such decision involves alleged fraud breach this agreement construction interpretation term condition thereof which case matter shall resolved under section nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color expense resolution firm including third party support staff other cost incurred with respect carrying procedure specified direction independent expert connection with such audit disagreement shall borne each party inverse proportion disputed amount awarded party resolution firm through such decision party dispute independent expert award party then party forty percent party sixty percent resolution firm cost font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color confidentiality font font style font weight normal color nbsp nbsp each party will treat information subject review under section accordance with provision section will cause accounting firm independent expert enter into reasonably acceptable confidentiality agreement with audited party obligating such entity maintain such financial information confidence pursuant such confidentiality agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color payment term interest nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color payment under this agreement shall made dollar wire transfer immediately available fund account commercial bank designated symbioscience such designation writing provided calithera least business before payment nbsp nbsp payment under this agreement shall such date specified agreement event that such date business next succeeding business nbsp nbsp payment based invoice shall made within thirty from calithera receipt such invoice font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color calithera make payment that owed under term this agreement date when then calithera shall obligated computed simple interest interest period commencing from such date ending date that payment amount owed actually made interest rate annum equal font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color quoted date highest rate allowed whichever lower interest calculation shall based computation method such interest shall payable tender underlying principal payment font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color withholding font font style font weight normal color nbsp nbsp symbioscience will responsible income other owed symbioscience required applicable withheld deducted from royalty other payment made behalf calithera symbioscience hereunder font font style color withholding font font style font weight normal color calithera deduct from amount that calithera required hereunder symbioscience amount equal such withholding required calithera withheld paid proper authority nbsp nbsp symbioscience will provide calithera information available symbioscience that necessary determine withholding nbsp nbsp such withholding will paid proper taxing authority symbioscience account evidence such payxment will secured sent symbioscience within such payment nbsp nbsp party will reasonable effort such lawful sign such lawful deed document either party reasonably request from other party enable symbioscience calithera affiliate sublicensees take advantage applicable legal provision double taxation treaty with object paying symbioscience hereunder without minimize amount such withholding deduction withholding font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color intellectual property right font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color filing prosecution maintenance licensed patent font font style font weight normal color nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color accordance with this section unless party otherwise agree writing long calithera retains exclusive right hereunder calithera will have lead responsibility symbioscience shall cooperate fully with respect preparation filing prosecution enforcement maintenance territory licensed patent identified font font style text decoration underline font weight normal color exhibit font font style font weight normal color nbsp nbsp calithera shall responsible cost expense including reasonable pocket cost incurred symbioscience performing related activity prior written request calithera with respect such activity nbsp nbsp calithera will perform such activity through patent counsel choice reasonably acceptable symbioscience nbsp nbsp calithera will provide symbioscience with copy official correspondence received from patent office with proposed substantive response thereto sufficiently advance calithera provide comment suggestion such proposed response nbsp nbsp calithera will provide symbioscience with update filing prosecution maintenance status each licensed patent periodic basis nbsp nbsp event that calithera elect pursue continue filing prosecution maintenance licensed patent country calithera shall provide symbioscience with font font style color font font style font weight normal color notice this decision least thirty prior pending lapse abandonment thereof provide symbioscience with opportunity assume responsibility such filing prosecution maintenance nbsp nbsp event that symbioscience elect writing assume responsibility such filing prosecution maintenance symbioscience shall have right transfer responsibility such filing prosecution maintenance such patent application patent patent counsel outside internal selected calithera shall cooperate with symbioscience reasonably requested facilitate transfer control such filing prosecution maintenance nbsp nbsp clarity filing with respect licensed patent shall time continue pursued name symbioscience designee nbsp nbsp event that symbioscience assumes responsibility such licensed patent provided above with respect such filing prosecution maintenance font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color enforcement font font style font weight normal color name _dv_m font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color initiation font font style font weight normal color either party learns infringement threatened infringement third party licensed patent such party shall promptly notify other party shall provide such other party with available evidence such infringement nbsp nbsp calithera shall have first right obligation sole expense bring suit other appropriate legal action against actual suspected infringement licensed patent relating development commercialization licensed product field territory nbsp nbsp calithera take such action within hundred twenty after written notice from symbioscience such infringement then written request symbioscience with calithera prior written consent unreasonably withheld symbioscience shall have right obligation expense bring suit other appropriate legal action against such infringement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color name _dv_m cooperation nbsp nbsp font font style font weight normal color each party shall execute paper perform such other other than monetary reasonably required maintain infringement suit brought accordance with section above including giving legal consent bringing such suit also name behalf calithera option expense represented such suit counsel choice addition party shall cooperate with each other font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color obtaining patent term restoration supplemental protection certificate their equivalent country where applicable licensed patent event that election with respect obtaining such patent term restoration supplemental protection certificate their equivalent made party shall agree upon such election font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color recovery nbsp nbsp font font style font weight normal color amount recovered whether judgment settlement shall first applied reimburse cost expense including attorney party bringing suit then cost expense including attorney other party nbsp nbsp calithera brings suit then calithera shall retain amount recovered after payment cost expense above such recovery shall deemed sale calendar quarter received calithera shall symbioscience royalty thereon under section nbsp nbsp symbioscience brings such suit then such amount recovery remaining after payment cost expense above shall allocated symbioscience calithera suit brought jointly font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color defense infringement claim font font style font weight normal color name _dv_m nbsp nbsp manufacture sale licensed product pursuant this agreement result result claim suit proceeding third party alleging patent infringement calithera affiliate sublicensees field territory calithera will promptly notify symbioscience thereof writing nbsp nbsp calithera affiliate sublicensee will have exclusive right defend control defense such claim suit action proceeding expense using counsel choice settle such claim suit action proceeding sole discretion font font style font style italic font weight normal color provided font font style font weight normal color name _dv_m that such settlement would admit concede that material aspect licensed patent invalid unenforceable require symbioscience amount aspect such settlement directly involving such admission concession payment shall require prior written consent symbioscience nbsp nbsp calithera will keep symbioscience reasonably informed material development connection with such claim suit proceeding nbsp nbsp calithera agrees provide symbioscience with copy material pleading filed such action allow symbioscience reasonable opportunity comment defense claim provided that calithera shall have obligation disclose matter that covered attorney client privilege work product privilege nbsp nbsp font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size name _dv_m font style font variant small text transform none color representation warranty covenant font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color symbioscience warranty font font style font weight normal color name _dv_c nbsp nbsp symbioscience hereby warrant represents calithera effective date that name _dv_x name _dv_c name _dv_c symbioscience right grant license under licensed technology forth this agreement name _dv_m name _dv_c symbioscience entered into agreement arrangement understanding that conflict with term this agreement symbioscience owns control entire right title interest licensed technology symbioscience affiliate have granted third party license right option other right under licensed technology that conflict with term this agreement effective date symbioscience aware patent right owned third party that would infringed practice licensed technology field territory under license granted section patent right owned licensed symbioscience affiliate that licensed patent which license likely would required practice licensed technology field territory under license granted section prior other fact circumstance that would reasonably lead symbioscience affiliate believe that licensed patent likely invalid unenforceable none licensed technology been misappropriated from third party nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color reciprocal representation warranty font font style font weight normal color each party represents warrant other party that nbsp nbsp this agreement legal valid obligation binding upon execution enforceable against accordance with term condition execution delivery performance this agreement such party been duly authorized necessary corporate action person executing this agreement behalf such party been duly authorized requisite corporate action font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style text transform uppercase color disclaimer warranty font font style text transform uppercase font weight normal color nbsp nbsp except express warranty forth section neither party make representation grant other warranty express implied either fact operation statute otherwise symbioscience calithera each specifically disclaims other warranty whether written oral express implied including warranty quality merchantability font font style text transform uppercase font weight normal warranty validity enforceability patent infringement intellectual property right third party font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color confidentiality font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color definition nbsp nbsp font font style font weight normal color during term party font font style color disclosing party font font style font weight normal color with respect information disclosed such party disclose otherwise communicate other party font font style color receiving party font font style font weight normal color with respect information disclosed such party other party information connection with this agreement performance obligation hereunder font font style color confidential information font font style font weight normal color disclosing party which include scientific manufacturing information plan marketing business plan financial personnel matter relating party present future product sale supplier customer employee investor business nbsp nbsp without limiting foregoing confidential information party hereby deemed include information disclosed such party other party pursuant that certain confidentiality agreement between party dated font font style color prior font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color exclusion nbsp nbsp font font style font weight normal color notwithstanding foregoing information disclosed disclosing party will deemed confidential information with respect receiving party purpose this agreement such information font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color already known receiving party affiliate evidenced their written record other than under obligation confidentiality time disclosure receiving party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color generally available otherwise part public domain time disclosure receiving party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color became generally available otherwise became part public domain after disclosure receiving party through fault breach obligation under this section prior receiving party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color disclosed receiving party other than under obligation confidentiality third party obligation party that control such information know disclose such information know others lawful right disclose font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color independently discovered developed receiving party affiliate evidenced written record without confidential information belonging disclosing party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color disclosure font restriction font style font weight normal font font style font weight normal color except expressly otherwise provided herein each party agrees that during term year font font style color font font style font weight normal color thereafter such party receiving party with respect confidential information other party affiliate sublicensees will keep font font style font weight normal completely font font style font weight normal color confidential will publish otherwise disclose will purpose except purpose contemplated this agreement confidential information disclosing party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color authorized font disclosure font style font weight normal color nbsp nbsp receiving party disclose specific confidential information disclosing party extent that such disclosure font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color required valid order court competent jurisdiction other governmental regulatory body competent jurisdiction font font style font style italic font weight normal color provided font font style font weight normal color that such receiving party will first have given reasonable prior notice such disclosure requirement disclosing party given disclosing party reasonable opportunity quash such order obtain protective order limiting such disclosure requiring that confidential information document that subject such order held confidence such court governmental regulatory body disclosed used only purpose which order issued font font style font style italic font weight normal color provided font font style font weight normal color font font style font style italic font weight normal color further font font style font weight normal color font font style font style italic font weight normal color font font style font weight normal color that disclosure requirement quashed confidential information disclosed response such court governmental order will limited that information that legally required disclosed response such court governmental order taking into account protective other similar order limiting such disclosure obligation font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color required font font style font style italic font weight normal color provided font font style font weight normal color that disclosing party will provide receiving party with notice such disclosure advance thereof extent practicable disclosure will limited that information that legally required disclosed response such court governmental order font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color made receiving party regulatory authority required connection with regulatory filing application made accordance with term this agreement font font style font style italic font weight normal color provided font font style font weight normal color that reasonable measure will taken assure confidential treatment such information font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color made receiving party reasonably required connection with performance this agreement affiliate employee consultant representative agent each whom prior disclosure must bound obligation confidentiality least equivalent scope those forth this section font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color made receiving party existing potential acquirer merger candidate potential sublicensees collaborator extent contemplated hereunder investment banker existing potential investor venture capital firm other financial institution investor purpose obtaining financing affiliate each whom prior disclosure must bound obligation confidentiality least equivalent scope those forth this section font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color made receiving party with prior written consent disclosing party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color name font font style font weight normal color nbsp nbsp neither party make public other party name except connection with announcement other disclosure relating this agreement activity contemplated hereby permitted section required applicable otherwise agreed writing such other party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color press release font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal party have mutually agreed press release issued calithera announcing execution this agreement which attached hereto font font style text decoration underline font weight normal exhibit font font style font weight normal color subsequent press release other written public disclosure relating this agreement party relationship hereunder each font font style color public disclosure font font style font weight normal color each party will reasonable effort submit other party draft such public disclosure review comment other party least five full business prior date which such party plan release such public disclosure event will submit such draft least hour prior release such public disclosure will review consider good faith comment provided response font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color party unable comply with foregoing hour notice requirement because legal obligation stock exchange requirement make more rapid disclosure such party will breach this agreement will that case give telephone email notice senior executive other party provide draft disclosure with much notice possible prior release such public disclosure font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color party publicly disclose without regard preceding requirement this section information that previously disclosed public disclosure that compliance with such requirement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color term agreement maintained confidence nbsp nbsp font font style font weight normal color party agree that term this agreement confidential will disclosed either party third party except party professional advisor without prior written permission other party font font style font style italic font weight normal color provided font font style font weight normal color that either party make filing this agreement required regulation country long such party reasonable effort obtain confidential treatment portion this agreement available consults with other party permit other party participate extent practicable seeking protective order other confidential treatment font font style font style italic font weight normal color provided further font font style font weight normal color that party publicly disclose without regard preceding requirement this section information that previously disclosed compliance with such requirement font font style font style italic font weight normal color provided further font font style font weight normal color that party disclose such term confidence provided section font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color term termination font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color term font font style font weight normal color nbsp nbsp term this agreement will commence effective date will expire upon expiration last royalty term licensed product country territory will terminate agreement earlier terminated accordance with this section such period font font style color term font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color termination material breach font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color material failure party font font style color breaching party font font style font weight normal color comply with material obligation contained this agreement such failure font font style color material breach font font style font weight normal color will entitle other party font font style color breaching party font font style font weight normal color give breaching party written notice material breach which notice shall specify detail nature breach shall require breaching party make good otherwise cure such material breach font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color such material breach cured within after receipt notice pursuant section above subject section breaching party will entitled terminate this agreement written notice font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color breaching party without prejudice other right conferred this agreement other remedy available under applicable font font style font style italic font weight normal color provided that font font style font weight normal color allegedly breaching party notifies breaching party writing within receipt relevant notice breach provided pursuant section that dispute good faith that committed material breach that timely cured such breach provides information justifying position such dispute then such termination shall effective unless until dispute resolved favor breaching party nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color termination will font font style font weight normal color nbsp nbsp calithera terminate this agreement will upon prior written notice symbioscience font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color consequence expiration termination font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color expiration nbsp nbsp font font style font weight normal color upon expiration royalty term particular country given licensed product calithera license under section with respect such licensed product field such country will become exclusive irrevocable perpetual fully paid license font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color early termination material breach calithera nbsp nbsp font font style font weight normal color upon termination this agreement pursuant section termination symbioscience material breach calithera pursuant section following provision will apply font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color right license granted symbioscience calithera under this agreement will terminate immediately font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color promptly later than within sixty after such termination calithera will upon symbioscience request under commercially reasonable term assign symbioscience calithera right title interest agreement between calithera third party that freely assignable calithera that relate directly solely development commercialization licensed product nbsp nbsp extent that agreement described this section assignable calithera then such agreement will assigned upon request symbioscience calithera will cooperate good faith diligent effort obtain symbioscience right assign such agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color calithera will upon symbioscience request transfer symbioscience designee management continued performance clinical trial licensed product ongoing effective date such termination font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color extent requested symbioscience calithera will transfer symbioscience stock licensed product held calithera affiliate purchased symbioscience font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color each calithera sublicensees with respect affected licensed product affected country such time will continue have right license forth their sublicense agreement subject continued performance obligation thereunder provided however that such sublicensee agrees writing that symbioscience entitled enforce relevant term condition such sublicense agreement directly against such sublicensee provided further that such sublicensee then breach sublicense agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color material breach symbioscience nbsp nbsp font font style font weight normal color upon termination this agreement calithera material breach symbioscience pursuant section without limiting other remedy available under applicable calithera elected calithera writing continue practice license granted section accordance with term this agreement font font style color font font style font weight normal color except that obligation under section shall longer apply calithera solely event that such termination based breach provision section symbioscience associated payment forth article with respect such license shall reduced font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color survival font font style font weight normal color nbsp nbsp expiration termination this agreement will relieve party obligation accruing prior such expiration termination nbsp nbsp provision section will survive termination expiration this agreement font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color indemnification insurance font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color indemnification symbioscience nbsp nbsp font font style font weight normal color symbioscience will indemnify calithera affiliate sublicensees their respective director officer employee agent defend hold each them harmless from font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color against loss damage liability cost expense including reasonable attorney expense collectively font font style color loss font font style font weight normal color based suffered connection with liability suit investigation allegation action claim demand third party font font style color third party claim font font style font weight normal color extent arising from occurring result connection with breach symbioscience representation warranty other obligation under this agreement gross negligence willful misconduct symbioscience affiliate except extent that such loss third party claim arise result from gross negligence willful misconduct party seeking indemnification hereunder breach calithera provision this agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color indemnification calithera nbsp nbsp font font style font weight normal color calithera will indemnify symbioscience affiliate their respective director officer employee agent defend save each them harmless from against loss based suffered connection with third party claim against such indemnified party arising from occurring result connection with theory product liability including action form tort warranty strict liability concerning licensed product that developed commercialized calithera affiliate sublicensees breach calithera representation warranty obligation under this agreement gross negligence willful misconduct calithera affiliate sublicensees except extent that such loss third party claim arise result from gross negligence willful misconduct party seeking indemnification hereunder breach symbioscience provision this agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color indemnification procedure font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color notice claim font font style font weight normal color nbsp nbsp indemnified party will give indemnifying party font font style color indemnifying party font font style font weight normal color prompt written notice font font style color indemnification claim notice font font style font weight normal color loss discovery fact upon which such indemnified party intends base request indemnification under section section font font style font style italic font weight normal color provided however font font style font weight normal color that failure give such prompt written notice will relieve indemnifying party indemnification obligation under this agreement except only extent that indemnifying party actually prejudiced result such failure nbsp nbsp event will indemnifying party liable loss that result from delay providing such notice nbsp nbsp each indemnification claim notice must contain description claim nature amount such loss extent that nature amount such loss known such time nbsp nbsp indemnified party will furnish promptly indemnifying party copy paper official document received respect loss nbsp nbsp indemnification claim respect party affiliate their respective director officer employee agent collectively font font style color indemnitees font font style font weight normal color each font font style color indemnitee font font style font weight normal color will made solely such party this agreement font font style color indemnified font font style font weight normal color font font style color party font font style font weight normal color font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color control defense font font style font weight normal color nbsp nbsp option indemnifying party assume defense third party claim giving written notice indemnified party within after indemnifying party receipt indemnification claim notice nbsp nbsp upon assuming defense third party claim indemnifying party appoint lead counsel defense third party claim legal counsel selected indemnifying party nbsp nbsp event indemnifying party assumes defense third party claim indemnified party will immediately deliver indemnifying party original notice document including court paper received indemnitee connection with third party claim nbsp nbsp should indemnifying party assume defense third party claim indemnifying party will liable indemnified party other indemnitee legal expense subsequently incurred such indemnified party other indemnitee connection with analysis defense settlement third party claim font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color right participate defense font font style font weight normal color nbsp nbsp without limiting section above indemnitee will entitled participate control defense such third party claim employ counsel choice such purpose font font style font style italic font weight normal color provided font font style font weight normal color that such employment will indemnitee expense unless employment thereof been specifically authorized indemnifying party writing indemnifying party failed assume defense employ counsel accordance with section which case indemnified party will control defense font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color settlement font font style font weight normal color nbsp nbsp with respect loss relating solely payment money damage connection with third party claim that will result indemnitee becoming subject injunctive other relief otherwise adversely affect business indemnitee manner which indemnifying party will have acknowledged writing obligation indemnify indemnitee hereunder indemnifying party will have sole right consent entry judgment enter into settlement otherwise dispose such loss such term indemnifying party sole discretion will deem appropriate will transfer indemnified party amount which said indemnified party will liable prior time prior entry judgment nbsp nbsp with respect other loss connection with third party claim where indemnifying party assumed defense third party claim accordance with section indemnifying party will have authority consent font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color entry judgment enter into settlement otherwise dispose such loss provided obtains prior written consent indemnified party which consent will indemnified party sole absolute discretion nbsp nbsp indemnifying party will liable settlement other disposition loss indemnitee that reached without written consent indemnifying party nbsp nbsp regardless whether indemnifying party chooses defend prosecute third party claim indemnitee will admit liability with respect settle compromise discharge third party claim without prior written consent indemnifying party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color cooperation font font style font weight normal color nbsp nbsp indemnified party will will cause each other indemnitee cooperate defense prosecution thereof will furnish such record information testimony provide such witness attend such conference discovery proceeding hearing trial appeal reasonably requested connection with defense prosecution third party claim nbsp nbsp such cooperation will include access during normal business hour afforded indemnifying party reasonable retention indemnified party record information that reasonably relevant such third party claim making indemnitees other employee agent available mutually convenient basis provide additional information explanation material provided hereunder indemnifying party will reimburse indemnified party reasonable pocket expense connection therewith font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color expense font font style font weight normal color nbsp nbsp except provided above reasonable verifiable cost expense including disbursement counsel incurred indemnified party connection with claim will reimbursed calendar quarter basis indemnifying party without prejudice indemnifying party right contest indemnified party right indemnification subject refund event indemnifying party ultimately held obligated indemnify indemnified party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color insurance font font style font weight normal color nbsp nbsp each party will have maintain such type amount liability insurance normal customary industry generally party similarly situated will upon request provide other party with copy policy insurance that regard along with amendment revision thereto font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color limitation liability font table style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal event will either party liable other party lost profit loss data special indirect incidental consequential punitive damage however caused theory liability whether such party been advised possibility such damage arising under cause action arising this agreement nbsp nbsp foregoing limitation will apply award enhanced damage available under patent willful patent infringement will limit either party obligation other party under section this agreement align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight bold color font size font family arial text transform uppercase font style normal font variant normal valign style width style margin bottom margin font weight bold color text transform uppercase font style normal font variant normal font family arial font size font style font variant small text transform none color miscellaneous font table style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color assignment font font style font weight normal color nbsp nbsp without prior written consent other party hereto which consent shall unreasonably withheld party will sell transfer assign delegate pledge otherwise dispose whether voluntarily involuntarily operation otherwise this agreement right duty hereunder font font style color font font style font style italic font weight normal color provided font font style font weight normal color that party hereto assign transfer this agreement right obligation hereunder without consent other party nbsp nbsp affiliate such party third party with which merges consolidates which transfer substantially asset which this agreement relates provided that foregoing consent obligation shall limit ability grant sublicenses permitted this agreement engage subcontractor perform certain obligation hereunder nbsp nbsp assigning party except surviving entity will remain jointly severally liable with relevant affiliate third party assignee under this agreement relevant affiliate assignee third party assignee surviving entity will assume writing assigning party obligation under this agreement nbsp nbsp purported assignment transfer violation this section will void font font style font style italic font weight normal color initio font font style font weight normal color force effect font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color severability font font style font weight normal color nbsp nbsp provision this agreement held illegal invalid unenforceable under present future right obligation either party under this agreement will materially adversely affected thereby such provision will fully severable this agreement will construed enforced such illegal invalid unenforceable provision never comprised part hereof remaining provision this agreement will remain full force effect will affected illegal invalid unenforceable provision severance herefrom lieu such illegal invalid unenforceable provision there will added automatically font style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color part this agreement legal valid enforceable provision similar term such illegal invalid unenforceable provision possible reasonably acceptable party herein nbsp nbsp fullest extent permitted applicable each party hereby waif provision that would render provision prohibited unenforceable respect font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color governing dispute resolution font font style font weight normal color nbsp nbsp font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color this agreement dispute between party related arising this agreement including party relationship created hereby negotiation entry into this agreement conclusion binding effect amendment coverage termination performance alleged performance party obligation under this agreement each font font style color dispute font font style font weight normal color will governed state york without reference choice principle thereof that would cause application different jurisdiction font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color event dispute party notify other party writing such dispute party will settle such dispute amicably between themselves nbsp nbsp party unable resolve dispute within receipt written notice other party such dispute will referred chief executive officer each party their respective designees will their good faith effort resolve dispute within after referred chief executive officer font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color event that dispute resolved provided section whether before after termination this agreement either party refer such dispute resolution court competent jurisdiction font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style font weight normal color notwithstanding foregoing nothing this section will limit either party right seek immediate temporary injunctive other temporary equitable relief whenever fact circumstance would permit party seek such relief court competent jurisdiction font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color notice nbsp nbsp font font style font weight normal color notice other communication that required permitted hereunder will writing delivered personally sent facsimile promptly confirmed personal delivery overnight courier provided herein sent internationally recognized overnight courier addressed follows font style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal symbioscience style margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal symbioscience style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal seneca meadow parkway style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal germantown maryland style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal attention chief counsel style margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal with copy style text align justify margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal style text align justify margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal street style text align justify margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal mclean style text align justify margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal attention general counsel style margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal calithera style margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal calithera bioscience style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal oyster point boulevard suite style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal south francisco style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal attention curtis hecht vice president business development style margin margin bottom margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal with copy facsimile style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal such other address party whom notice given have furnished other party writing accordance herewith nbsp nbsp such communication will deemed have been given when delivered personally delivered sent facsimile business second business after dispatch sent internationally recognized overnight courier nbsp nbsp understood agreed that this section intended govern business communication necessary between party performing their duty course under term this agreement style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color entire agreement modification nbsp nbsp font font style font weight normal color this agreement including exhibit attached hereto each which hereby incorporated made part this agreement reference forth constitutes entire agreement understanding between party with respect subject matter hereof prior agreement understanding promise representation whether written oral with respect thereto nbsp nbsp each party confirms that relying representation warranty other party except specifically forth herein nbsp nbsp amendment modification this agreement will binding upon party unless writing duly executed authorized representative both party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color relationship party nbsp nbsp font font style font weight normal color expressly agreed that party relationship under this agreement strictly pure contract relationship between symbioscience calithera that this agreement create constitute partnership joint venture agency font font style color nbsp nbsp font font style font weight normal color neither party will have authority make statement representation commitment kind take action which will binding purport binding other font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color waiver font font style font weight normal color nbsp nbsp term condition this agreement waived time party that entitled benefit thereof such waiver will effective unless forth written instrument duly executed behalf party waiving such term condition nbsp nbsp waiver either party hereto right hereunder claim based failure perform breach other party will deemed waiver other right hereunder other breach failure said other party whether similar nature otherwise font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color counterpart font font style font weight normal color nbsp nbsp this agreement executed more counterpart each which will deemed original which together will constitute same instrument font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color benefit third party font font style font weight normal color nbsp nbsp representation warranty covenant agreement forth this agreement sole benefit party hereto their successor permitted assigns they will construed conferring right other party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color further assurance font font style font weight normal color nbsp nbsp each party will duly execute deliver cause duly executed delivered such further instrument cause done such further thing including filing such assignment agreement document instrument necessary other party reasonably request connection with this agreement carry more effectively provision purpose better assure confirm unto such other party right remedy under this agreement font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color english language font font style font weight normal color nbsp nbsp this agreement been written executed english language used united state america will interpreted accordance with english language used united state america nbsp nbsp translation party into other language will official version thereof event conflict interpretation between english version such translation english version will control font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color drafting party font font style font weight normal color nbsp nbsp this agreement been submitted scrutiny been negotiated both party their counsel will given fair reasonable interpretation accordance with term without consideration weight being given such term having been drafted party counsel nbsp nbsp rule strict construction will applied against either party font style margin bottom margin text indent font weight bold color font size font family arial font style normal text transform none font variant normal font style color construction font font style font weight normal color nbsp nbsp except where context otherwise requires wherever used gender will applicable gender word used inclusive sense nbsp nbsp caption this agreement convenience reference only define describe extend limit scope intent this agreement intent provision contained this agreement term including used herein mean including without limiting generality description preceding such term word will mean unless otherwise clearly indicated context nbsp nbsp unless context requires otherwise definition reference agreement instrument other document refer such agreement instrument other document from time time amended supplemented otherwise modified subject restriction such amendment supplement modification forth herein therein reference refer such from time time enacted repealed amended word herein hereof hereunder word similar import refer this agreement entirety particular provision hereof reference herein section exhibit unless otherwise specifically provided refer section exhibit this agreement font style text align center margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal remainder page intentionally left blank nbsp nbsp signature page follows style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style text align center margin margin bottom text indent font size font family arial font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font weight bold color font family arial font variant small font size font style normal text transform none witness whereof font style font weight normal font variant normal party have executed this agreement their respective authorized representative date first written above font style margin bottom margin text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width colspan valign bottom style width style margin bottom margin margin left text indent font weight bold font size font family arial font variant small font style normal text transform none through division symbioscience valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family time roman nbsp valign bottom style width border bottom solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal frank valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border solid style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal name valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family time roman nbsp valign bottom style width border bottom solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal frank valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border solid style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal title valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family time roman nbsp valign bottom style width border bottom solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal president valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border solid style margin bottom margin margin left text indent font family time roman font size nbsp colspan valign bottom style width style margin bottom margin margin left text indent font weight bold font family arial font variant small font size font style normal text transform none calithera bioscience valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family time roman nbsp valign bottom style width border bottom solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal susan molineaux valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border solid style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal name valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family time roman nbsp valign bottom style width border bottom solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal susan molineaux valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border solid style margin bottom margin margin left text indent font family time roman font size nbsp valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal title valign bottom style width border bottom solid transparent style margin bottom margin margin left text indent font family time roman nbsp valign bottom style width border bottom solid style margin bottom margin margin left text indent font family arial font size font weight normal font style normal text transform none font variant normal president table style margin bottom margin text indent font family time roman nbsp style margin bottom margin text indent font family time roman nbsp style margin bottom margin text indent font family time roman nbsp style margin margin bottom text indent font size font family calibri font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font family arial font variant small font size font style normal text transform none exhibit style text align center margin margin bottom text indent font weight bold font family arial font variant small font size font style normal text transform none licensed patent style margin bottom margin text indent font family time roman font weight bold font size nbsp table border cellspacing cellpadding align center style border collapse collapse width style width style width style width style width style width style width style height valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal title valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal country valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal application valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal date filed valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal status valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent font weight bold font family arial font size font style normal text transform none font variant normal style height valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent color font family arial font size font weight normal font style normal text transform none font variant normal valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent color font family arial font size font weight normal font style normal text transform none font variant normal valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent color font family arial font size font weight normal font style normal text transform none font variant normal valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent color font family arial font size font weight normal font style normal text transform none font variant normal valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent color font family arial font size font weight normal font style normal text transform none font variant normal valign middle style border solid border bottom solid border left solid border right solid style text align center margin bottom margin margin left text indent color font family arial font size font weight normal font style normal text transform none font variant normal table style margin bottom margin text indent font family time roman nbsp style margin bottom margin text indent font family time roman nbsp style text align center margin bottom margin text indent font family time roman nbsp style margin margin bottom text indent font size font family calibri font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font family arial font variant small font size font style normal text transform none exhibit style text align center margin margin bottom text indent font weight bold font family arial font variant small font size font style normal text transform none example proportional sale milestone payment align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size there tier product with total annual sale table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size milestone payment will font style font weight bold text decoration underline font table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size there licensed product tier product with annual sale other tier product with annual sale nbsp nbsp total there annual sale triggering milestone payment proportional contribution each product table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size tier product contributes total sale milestone objective associated payment reduced proportionally table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size tier product contributes total sale milestone objective payment reduced proportionally table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font weight normal font style normal text transform none font variant normal font family wingdings valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family wingdings font size font style font family arial total milestone payment would font font style font weight bold text decoration underline font family arial font table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size there three licensed product tier product sale tier product sale tier product sale table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size tier product would contribute table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size tier product would contribute table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font family arial font weight normal font style normal text transform none font variant normal valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family arial font size tier product would contribute table align left table border cellspacing cellpadding style border collapse collapse width margin left valign style width white space nowrap style margin bottom margin font size font weight normal font style normal text transform none font variant normal font family wingdings valign style width style margin bottom margin font weight normal font style normal text transform none font variant normal font family wingdings font size font style font family arial total milestone payment would font font style font weight bold text decoration underline font family arial font table style margin bottom margin text indent font family time roman nbsp style margin bottom margin text indent font family time roman nbsp style margin bottom margin text indent font family time roman nbsp style margin margin bottom text indent font size font family calibri font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font family arial font variant small font size font style normal text transform none exhibit style text align center margin margin bottom text indent font weight bold font family arial font variant small font size font style normal text transform none press release style margin margin bottom text indent font weight bold font family arial font size font style normal text transform none font variant normal title style width height style margin margin bottom text indent font weight bold font family arial font size font style normal text transform none font variant normal calithera bioscience gain exclusive worldwide license symbioscience arginase inhibitor style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal south francisco calif globe newswire calithera bioscience nasdaq cala announced today signing exclusive global license agreement with symbioscience symbioscience division incorporated granting calithera right research develop commercialize symbioscience portfolio arginase inhibitor discovered part cocoa flavanol research program human healthcare symbioscience preclinical arginase inhibitor program will enhance calithera effort submit investigational drug application arginase inhibitor with treatment cancer near style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal believe that drug targeting immuno oncology tumor metabolism pathway have potential transformational treatment cancer calithera dedicated researching developing potential first class therapy that could significantly advance these promising field research said susan molineaux president calithera bioscience particularly excited about this agreement because believe apply core expertise tumor biology rapidly advance symbioscience potent selective small molecule arginase inhibitor into clinic develop first class immuno oncology therapy cancer patient style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal under term agreement calithera will obtain exclusive worldwide right symbioscience arginase inhibitor drug research development commercialization nbsp nbsp symbioscience will receive upfront payment will eligible receive future development commercialization milestone well royalty sale approved product style background color ffffff margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal about tumor immunology arginase inhibitor style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal field tumor immunology focused developing agent that activate body immune system attack kill tumor calithera preclinical program tumor immunology focused developing selective inhibitor enzyme arginase enzyme produced myeloid derived suppressor cell tumor microenvironment that depletes arginine naturally occurring amino acid that critical activation growth survival body cancer fighting cytotoxic cell depletion arginine elevated level arginase been observed renal cell carcinoma acute myeloid leukemia patient inhibiting arginase possible restore tumor killing activity cytotoxic cell preventing depletion arginine nbsp nbsp symbioscience discovered novel compound that selectively potently inhibit arginase activity which have therapeutic potential treatment cancer style background color ffffff margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal about calithera bioscience style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal calithera bioscience clinical stage company focused discovering developing novel small molecule drug directed against tumor metabolism tumor immunology nbsp nbsp calithera lead clinical candidate first class inhibitor glutaminase critical enzyme tumor metabolism currently being tested patient with solid hematological cancer nbsp nbsp calithera bioscience headquartered south francisco nbsp nbsp more information about calithera bioscience please visit font style text decoration underline calithera font style background color ffffff margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal about symbioscience style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal symbioscience technology based health life science business focused evidence based product development first established symbioscience incubator business idea generated throughout business segment nbsp nbsp pioneering some most innovative breakthrough fundamental scientific research symbioscience developing solution that translate science into product which have positive impact people planet style margin margin bottom text indent font size font family calibri font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended style page break after always style margin bottom margin text indent font weight bold font family arial font size font style normal text transform none font variant normal title style width height style background color ffffff margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal forward looking statement style background color ffffff margin bottom margin text indent font size font family arial font weight normal font style normal text transform none font variant normal this news release contains forward looking statement calithera that involve risk uncertainty these statement include those related potential calithera rapidly move symbioscience potent selective small molecule arginase inhibitor into clinic develop first class immuno oncology therapy cancer patient that drug targeting immuno oncology that inhibition arginase activity have therapeutic potential treatment cancer potential tumor metabolism pathway transformational treatment cancer actual result differ from calithera expectation important factor that could cause actual result differ materially calithera arginase program other potential product candidate that calithera develops progress through clinical development receive required regulatory approval within expected timeline nbsp nbsp addition clinical trial confirm safety potency other product characteristic described assumed this press release such product candidate beneficial patient successfully commercialized failure meet expectation with respect foregoing matter have negative effect calithera stock price additional information concerning these other risk factor affecting calithera business found calithera filing with security exchange commission these forward looking statement guarantee future performance speak only date hereof except required calithera disclaims obligation update these forward looking statement reflect future event circumstance style background color ffffff margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal source font style font weight normal calithera bioscience incorporated font style background color ffffff margin bottom margin text indent font weight bold font size font family arial font style normal text transform none font variant normal contact font style font weight normal font style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal investor contact style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal jennifer mcnealey style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal font style text decoration underline calithera font style margin margin bottom text indent font family arial font size font weight normal font style normal text transform none font variant normal style margin margin bottom text indent font size font family calibri font weight normal font style normal text transform none font variant normal certain confidential information contained this document marked bracket been omitted filed separately with security exchange commission pursuant rule security exchange amended body html text document